Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential factors of Helicobacter pylori resistance to clarithromycin.
Serebrova S, Kurguzova D, Krasnykh L, Vasilenko G, Drozdov V, Lazareva N, Shikh E, Zhuravleva M, Rykova S, Eremenko N, Kareva E, Mirzaev K, Sychev D, Prokofiev A. Serebrova S, et al. Among authors: sychev d. Drug Metab Pers Ther. 2022 Aug 29;37(4):383-391. doi: 10.1515/dmpt-2021-0193. eCollection 2022 Dec 1. Drug Metab Pers Ther. 2022. PMID: 36027921
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty.
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T. Sychev DA, et al. Pharmgenomics Pers Med. 2018 Jul 25;11:127-137. doi: 10.2147/PGPM.S169277. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 30100750 Free PMC article.
The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes.
Mirzaev KB, Rytkin E, Ryzhikova KA, Grishina EA, Sozaeva ZA, Fedorinov DS, Konova OD, Giliarov MI, Belyakova GA, Andreev DA, Sychev DA. Mirzaev KB, et al. Among authors: sychev da. Drug Metab Pers Ther. 2018 Sep 25;33(3):109-118. doi: 10.1515/dmpt-2018-0006. Drug Metab Pers Ther. 2018. PMID: 30171809 Free article. No abstract available.
Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA).
Fedorinov DS, Mirzaev KB, Mustafina VR, Sychev DA, Maximova NR, Chertovskikh JV, Popova NV, Tarabukina SM, Rudykh ZA. Fedorinov DS, et al. Drug Metab Pers Ther. 2018 Dec 19;33(4):195-200. doi: 10.1515/dmpt-2018-0015. Drug Metab Pers Ther. 2018. PMID: 30325731
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V. Sychev D, et al. Drug Metab Pers Ther. 2020 Mar 5;35(1):/j/dmdi.2020.35.issue-1/dmpt-2019-0029/dmpt-2019-0029.xml. doi: 10.1515/dmpt-2019-0029. Drug Metab Pers Ther. 2020. PMID: 32134727
Pain pharmacogenetics.
Slepukhina MA, Ivashchenko DV, Sheina MA, Muradian AA, Blagovestnov DA, Sychev DA. Slepukhina MA, et al. Drug Metab Pers Ther. 2020 Aug 10;35(3). doi: 10.1515/dmpt-2020-2939. Drug Metab Pers Ther. 2020. PMID: 32776897 Review.
192 results